MYL12A Antikörper (N-Term)

Produktnummer ABIN104491

Hersteller Produkt- Nr.: 600-401-416

Produktdetails anti-MYL12A Antikörper

Target: MYL12A (Myosin, Light Chain 12A, Regulatory, Non-Sarcomeric (MYL12A))

Bindungsspezifität: N-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MYL12A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunoprecipitation (IP)

Hersteller Produkt- Nr.: 600-401-416

Hersteller: Rockland

Verwendungszweck: Myosin phospho S19/phospho S20 Antibody

Kreuzreaktivität (Details): This affinity purified antibody is directed against the regulatory light chain of smooth and non-muscle myosin. The antibody is phosphospecific and detects monophosphorylated and diphosphorylated forms of the protein.

Produktmerkmale: Synonyms: rabbit anti-Myosin p19/pS20 antibody, Myosin regulatory light chain 12A, Myosin regulatory light chain MRLC3, Myosin regulatory light chain 2 nonsarcomeric, Myosin RLC, MLC-2B, HEL-S-24, Epididymis secretory protein Li 24, MLCB

Aufreinigung: affinity purified antibody

Sterilität: Sterile filtered

Immunogen:

Immunogen: Human Myosin Light Chain phospho peptide corresponding to a region near the amino terminus of the human smooth/non-muscle form of myosin regulatory light chain conjugated to Keyhole Limpet Hemocyanin (KLH).

Immunogen Type: Conjugated Peptide

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Immunohistochemistry Dilution: 2.5 μg/mL

Application Note: Rabbit Anti-Myosin pS19/pS20 Antibody was tested by ELISA, immunohistochemistry, and western blotting. Immunoblotting was used to show reactivity with unstimulated and stimulated cardiac myocytes, 3T3 whole cell lysates, and regulatory light chain and smooth muscle phospho recombinant protein. The antibody was also reactive with the phosphorylated form of the immunizing peptide and minimally reactive with the non-phosphorylated form of the immunizing peptide. Although not tested, this antibody is likely functional by immunoprecipitation.

Western Blot Dilution: 1:500 - 1:2,000

Immunoprecipitation Dilution: 1:100

ELISA Dilution: 1:10,000 - 1:30,000

Other: User Optimized

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.92 mg/mL

Buffer:

Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

Stabilizer: None

Preservative: 0.01 % (w/v) Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

Haltbarkeit: 12 months

Referenzen für anti-MYL12A Antikörper (ABIN104491)

Harbom, Rudisill, Michel, Litwa, Beenhakker, McConnell: "The effect of rho kinase inhibition on morphological and electrophysiological maturity in iPSC-derived neurons." in: Cell and tissue research, Vol. 375, Issue 3, pp. 641-654, (2019) (PubMed).

Salomon, Gaston, Magescas, Duvauchelle, Canioni, Sengmanivong, Mayeux, Michaux, Campeotto, Lemale, Viala, Poirier, Minc, Schmitz, Brousse, Ladoux, Goulet, Delacour: "Contractile forces at tricellular contacts modulate epithelial organization and monolayer integrity." in: Nature communications, Vol. 8, pp. 13998, (2018) (PubMed).

Panousopoulou, Hobbs, Mason, Green, Formstone: "Epiboly generates the epidermal basal monolayer and spreads the nascent mammalian skin to enclose the embryonic body." in: Journal of cell science, Vol. 129, Issue 9, pp. 1915-27, (2017) (PubMed).

Logue, Cartagena-Rivera, Baird, Davidson, Chadwick, Waterman: "Erk regulation of actin capping and bundling by Eps8 promotes cortex tension and leader bleb-based migration." in: eLife, Vol. 4, pp. e08314, (2016) (PubMed).

Newell-Litwa, Badoual, Asmussen, Patel, Whitmore, Horwitz: "ROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity." in: The Journal of cell biology, Vol. 210, Issue 2, pp. 225-42, (2016) (PubMed).

Roland, Ricobaraza, Carrel, Jordan, Rico, Simon, Humbert-Claude, Ferrier, McFadden, Scheuring, Lenkei: "Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth." in: eLife, Vol. 3, pp. e03159, (2015) (PubMed).

Solanes, Heuzé, Maurin, Bretou, Lautenschlaeger, Maiuri, Terriac, Thoulouze, Launay, Piel, Vargas, Lennon-Duménil: "Space exploration by dendritic cells requires maintenance of myosin II activity by IP3 receptor 1." in: The EMBO journal, Vol. 34, Issue 6, pp. 798-810, (2015) (PubMed).

Fabbiano, Menacho-Márquez, Sevilla, Albarrán-Juárez, Zheng, Offermanns, Montero, Bustelo: "Genetic dissection of the vav2-rac1 signaling axis in vascular smooth muscle cells." in: Molecular and cellular biology, Vol. 34, Issue 24, pp. 4404-19, (2015) (PubMed).

Edelson, Brautigan: "The Discodermia calyx toxin calyculin a enhances cyclin D1 phosphorylation and degradation, and arrests cell cycle progression in human breast cancer cells." in: Toxins, Vol. 3, Issue 1, pp. 105-19, (2013) (PubMed).

Details zu MYL12A

Target: MYL12A (Myosin, Light Chain 12A, Regulatory, Non-Sarcomeric (MYL12A))

Andere Bezeichnung: MYL12A (MYL12A Produkte)

Hintergrund: Background: Myosin is the major component of thick muscle filaments, and is a long asymmetric molecule containing a globular head and a long tail. The molecule consists of two heavy chains each ~200,000 daltons, and four light chains each ~16,000 - 21,000 daltons. Activation of smooth and cardiac muscle primarily involves pathways that increase calcium levels and myosin phosphorylation, resulting in contraction. Myosin light chain phosphatase acts to regulate muscle contraction by dephosphorylating activated myosin light chain. This antibody is specific for the phosphorylated form of myosin light chain. The selected peptide sequence used to generate the polyclonal antibody is located near the amino terminal end of the polypeptide corresponding to the smooth/non-muscle form of myosin regulatory light chain found in cardiac myocytes in addition to smooth and non-muscle cells. This sequence differs from that of the sarcomeric/cardiac form of myosin regulatory light chain that has a different sequence around the phosphorylation site. Human and mouse have almost identical sequences. In human the phosphorylation site is pS19, while in mouse the site maps to pS20. Myosin may play a role in disorders such as cardiomyopathies. Anti-Myosin pS19/sP20 Antibody is useful for researcher interested in stem cell and enzyme researcher.

Gen-ID: 10627

UniProt: P19105